Author

Yuzhen Zhou

Dana-Farber Cancer InstituteORCID 0000-0003-0461-2963Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam S. KibeliD· 1 shared Amanda GarzaiD· 1 shared Breanna M. TitcheniD· 1 shared Daniel E. MichaudiD· 1 shared Eliezer M. Van AlleniD· 1 shared Elinor G. Sterner· 1 shared Filipe L.F. CarvalhoiD· 1 shared Hiba Siddiqui· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam S. KibelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Press BluePeer-reviewedAug 20, 2026

Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer

Filipe L.F. Carvalho, Ji‐Hyun Lee, Nikolaos Kalavros…·Eliezer M. Van Allen

This study identifies tumor-myeloid crosstalk as a driver of cisplatin resistance in bladder cancer and proposes PARP14 inhibition as a therapeutic strategy.

2 citationstop 3%

humanscRNA-seq

𝕏 PostBluesky